Health
FDA approves world's first RSV vaccine, a shot for adults ages 60 and up
The FDA has approved the world’s first RSV vaccine: a single-dose shot for adults ages 60 and up, made by pharma company GSK. GSK’s single-dose shot lowered the risk of severe illness by 94% in older adults. The Food and Drug Administration on Wednesday approved the world’s first RSV vaccine: a shot …
